Literature DB >> 12204357

Changes in calcium-binding protein expression in the auditory brainstem nuclei of the jaundiced Gunn rat.

Robert F Spencer1, Wayne T Shaia, Ann T Gleason, Aristides Sismanis, Steven M Shapiro.   

Abstract

Sensorineural hearing loss and auditory dysfunction are major sequelae of neonatal hyperbilirubinemia. The sites and cellular effects of bilirubin toxicity in the auditory brainstem pathway are not easily detected. Since altered intracellular calcium homeostasis may play a role in neuronal cell death, we hypothesized that the expression of calcium-binding proteins may be altered in the classic animal model of bilirubin neurotoxicity. The expression of the calcium-binding proteins, calbindin-D28k and parvalbumin, in the brainstem auditory pathway of homozygous recessive jaundiced (jj) Gunn rats was examined by light and electron microscopic immunohistochemistry at 18 days postnatally and compared to the findings obtained from age-matched non-jaundiced heterozygous (Nj) littermate control rats. Immunoreactive staining for both calbindin and parvalbumin was reduced in the cochlear nuclei and the superior olivary complex in jj rats. The extent of the reduction in immunoreactivity was related to the severity of the clinical symptoms. By contrast, immunoreactive staining in other brainstem areas (e.g., dorsal and ventral nuclei of the lateral lemniscus, inferior colliculus), thalamic (medial geniculate body) auditory areas, and neighboring non-auditory structures was similar in jaundiced and control rats. Calbindin-immunoreactive staining in the superior paraolivary and medial superior olivary nuclei in Nj rats was associated with myelinated axons, whereas parvalbumin-immunoreactive staining was localized postsynaptically in neuronal somata and dendrites. Immunoreactive staining for the calcium-binding proteins calbindin and parvalbumin in lower brainstem auditory nuclei shows abnormalities in areas susceptible to the effects of hyperbilirubinemia and provides a sensitive new way to assess bilirubin toxicity in the auditory system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204357     DOI: 10.1016/s0378-5955(02)00494-x

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  12 in total

Review 1.  Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.

Authors:  Jon F Watchko
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

2.  Effect of Hyperbilirubinemia on Medial Olivocochlear System in Newborns.

Authors:  Burak Karabulut; Mehmet Sürmeli; Şenol Bozdağ; İldem Deveci; Rıza Doğan; Çağatay Oysu
Journal:  J Int Adv Otol       Date:  2019-08       Impact factor: 1.017

Review 3.  Bilirubin-Induced Audiologic Injury in Preterm Infants.

Authors:  Cristen Olds; John S Oghalai
Journal:  Clin Perinatol       Date:  2016-02-15       Impact factor: 3.430

Review 4.  Movement disorders due to bilirubin toxicity.

Authors:  Jessica Rose; Rachel Vassar
Journal:  Semin Fetal Neonatal Med       Date:  2014-12-16       Impact factor: 3.926

Review 5.  Auditory neuropathy--neural and synaptic mechanisms.

Authors:  Tobias Moser; Arnold Starr
Journal:  Nat Rev Neurol       Date:  2016-02-19       Impact factor: 42.937

Review 6.  Audiologic impairment associated with bilirubin-induced neurologic damage.

Authors:  Cristen Olds; John S Oghalai
Journal:  Semin Fetal Neonatal Med       Date:  2015-01-07       Impact factor: 3.926

Review 7.  Bilirubin Encephalopathy.

Authors:  Shuo Qian; Prateek Kumar; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2022-05-19       Impact factor: 5.081

Review 8.  Review of bilirubin neurotoxicity I: molecular biology and neuropathology of disease.

Authors:  Sean M Riordan; Steven M Shapiro
Journal:  Pediatr Res       Date:  2019-10-10       Impact factor: 3.756

9.  Acute hyperbilirubinaemia induces presynaptic neurodegeneration at a central glutamatergic synapse.

Authors:  Martin D Haustein; David J Read; Joern R Steinert; Nadia Pilati; David Dinsdale; Ian D Forsythe
Journal:  J Physiol       Date:  2010-10-11       Impact factor: 5.182

Review 10.  Review of bilirubin neurotoxicity II: preventing and treating acute bilirubin encephalopathy and kernicterus spectrum disorders.

Authors:  Steven M Shapiro; Sean M Riordan
Journal:  Pediatr Res       Date:  2019-10-03       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.